Jazz Pharmaceuticals Announces Private Offering of $850 Million of Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases

Jazz Pharmaceuticals plc New York Ireland California

View original content:https://www.prnewswire.co.uk/news-releases/jazz-pharmaceuticals-announces-private-offering-of-850-million-of-exchangeable-senior-notes-due-2030-and-concurrent-ordinary-share-repurchases-302236598.html